APOE and Alzheimer disease: Despite APOE being the main lipoprotein of interest with regards to AD risk factors, the emerging role of the lipoprotein CLU (or APOJ) in regulating Aβ aggregation and cytotoxicity in the brain has led to growing interest in this protein as both a mediator and biomarker of AD.